cell mass regenerates probably through an ability to ‘sense’ <strong>the</strong> total mass <strong>of</strong> <strong>in</strong>sul<strong>in</strong>-produc<strong>in</strong>g<strong>cells</strong> and self-regulate accord<strong>in</strong>gly (Hardikar 2004). Still, <strong>the</strong> success <strong>of</strong> <strong>the</strong>se studies is low andsuch treatments will probably not be sufficient for cur<strong>in</strong>g diabetes.Replacement <strong>the</strong>rapy by external sources <strong>of</strong> β-like <strong>cells</strong> holds <strong>the</strong> potential <strong>of</strong> an <strong>in</strong>f<strong>in</strong>ite supply <strong>of</strong>donor material for transplantation. The <strong>in</strong>itial cell material may come from ei<strong>the</strong>r somatic (oradult) stem <strong>cells</strong> or embryonic stem (<strong>ES</strong>) <strong>cells</strong>, or may <strong>in</strong> time come from patient-specific <strong>in</strong>ducedpluripotent (iPS) <strong>cells</strong>. These cell types are described <strong>in</strong> detail <strong>in</strong> a later section.The immune system represents a major obstacle when discuss<strong>in</strong>g cell replacement-<strong>the</strong>rapies.Patients would ei<strong>the</strong>r have to be put on a life-long treatment <strong>of</strong> immune-suppressive drugs, withmany complications to follow, or o<strong>the</strong>r methods will have to be developed to overcome <strong>the</strong> attack<strong>of</strong> cell material by <strong>the</strong> recipient immune system (Ross<strong>in</strong>i et al. 1999). Encapsulation <strong>of</strong> <strong>the</strong>rapeutic<strong>cells</strong> is one such method. Despite limitations <strong>in</strong> nutrient supply to and transport <strong>of</strong> effectermoleculesfrom <strong>the</strong> transplanted <strong>cells</strong>, studies <strong>in</strong> rat show that <strong>the</strong>y can convey normo-glycaemia<strong>in</strong> steptozotoc<strong>in</strong>-<strong>in</strong>duced diabetic rats (Omer et al. 2005). Ano<strong>the</strong>r possibility is <strong>in</strong>duction <strong>of</strong>immunological tolerance (mixed chimaerism), which has been shown possible by bone-marrowtransplantation <strong>in</strong> mice (Ross<strong>in</strong>i et al. 1999; Blaha et al. 2005).Embryonic developmentTo appreciate <strong>the</strong> challenges <strong>of</strong> directed <strong>in</strong> vitro <strong>differentiation</strong> <strong>of</strong> <strong>ES</strong> <strong>cells</strong>, one must acquire athorough understand<strong>in</strong>g <strong>of</strong> embryonic development. In this <strong>the</strong>sis, focus will be on <strong>mouse</strong>development from zygote to pancreatic β <strong>cells</strong>, especially concentrat<strong>in</strong>g on <strong>the</strong> early development,as <strong>the</strong> work presented here is on <strong>mouse</strong> <strong>ES</strong> cell <strong>differentiation</strong> <strong>in</strong> <strong>the</strong> early steps <strong>towards</strong> β-like<strong>cells</strong>.From zygote to blastocystThe fertilized egg, <strong>the</strong> zygote, is a totipotent cell from which all tissues <strong>of</strong> <strong>the</strong> embryo proper, <strong>the</strong>germ l<strong>in</strong>e and extra-embryonic tissues arise. In mice, <strong>the</strong> zygote moves <strong>in</strong>to <strong>the</strong> uter<strong>in</strong>e tract <strong>of</strong> <strong>the</strong>female and matures along <strong>the</strong> way. By embryonic day 3.5 (E3.5), it has developed <strong>in</strong>to an ovalstructure, <strong>the</strong> blastocyst, consist<strong>in</strong>g <strong>of</strong> an <strong>in</strong>ner cell mass (ICM) at one end and <strong>the</strong> blastocoel at<strong>the</strong> o<strong>the</strong>r end. The ICM gives rise to i) <strong>the</strong> epiblast (also called <strong>the</strong> primitive ectoderm), which willlater form <strong>the</strong> embryo proper and ii) fac<strong>in</strong>g <strong>the</strong> blastocoel, <strong>the</strong> primitive endoderm, which willgive rise to <strong>the</strong> visceral and parietal endoderm (PE), form<strong>in</strong>g parts <strong>of</strong> <strong>the</strong> yolk sac and uter<strong>in</strong>e walll<strong>in</strong><strong>in</strong>g, respectively (Gardner 1983; Rossant 2004). Surround<strong>in</strong>g <strong>the</strong>se structures is <strong>the</strong>trophectoderm (TE), which will develop <strong>in</strong>to <strong>the</strong> foetal parts <strong>of</strong> <strong>the</strong> placenta, <strong>the</strong> chorion. At E4.5<strong>the</strong> blastocyst implants <strong>in</strong>to <strong>the</strong> uter<strong>in</strong>e wall, ga<strong>in</strong><strong>in</strong>g access to maternal blood vessels and <strong>the</strong>rebya supply <strong>of</strong> nutrients and oxygen.The ICM expresses Octamer-4 (Oct4; encoded by Pou5f1), which is down-regulated <strong>in</strong> <strong>the</strong> TE(Nichols et al. 1998) and Nanog, which is ma<strong>in</strong>ta<strong>in</strong>ed <strong>in</strong> <strong>the</strong> epiblast but down-regulated <strong>in</strong> <strong>the</strong> PE(Mitsui et al. 2003). Oct4 –/– and Nanog –/– embryos die due to a failure to form <strong>the</strong> ICM or <strong>the</strong>epiblast, respectively. Also, Sex determ<strong>in</strong><strong>in</strong>g region Y (SRY)-box 2 (Sox2) is present <strong>in</strong> <strong>the</strong> ICM,possibly as remnants <strong>of</strong> maternally deposited prote<strong>in</strong> (Avilion et al. 2003). It is expressed by <strong>the</strong>embryo <strong>in</strong> <strong>the</strong> later epiblast and TE, where it, toge<strong>the</strong>r with OCT4 and nanog <strong>in</strong>ducestranscription <strong>of</strong> pluripotency-associated genes. The TE expresses Cdx2, a homeobox transcriptionfactor, which is required to form <strong>the</strong> placenta and to suppress transcription <strong>of</strong> Oct4 and Nanog(Chawengsaksophak et al. 2004; Strumpf et al. 2005). The PE expresses GATA-b<strong>in</strong>d<strong>in</strong>g prote<strong>in</strong> 6(GATA6; (Morrisey et al. 1998)). Recent studies have shown that <strong>cells</strong> <strong>in</strong> <strong>the</strong> ICM express bothnanog and GATA6 prote<strong>in</strong>s prior to segregation <strong>in</strong>to ei<strong>the</strong>r epiblast or PE <strong>cells</strong> <strong>in</strong> a mosaic pattern(Chazaud et al. 2006). It is <strong>the</strong> expression level <strong>of</strong> fibroblast growth factor (<strong>FGF</strong>) that regulateseach cell’s fate <strong>in</strong> such that low levels <strong>of</strong> <strong>FGF</strong> generate epiblast cell formation and high levels <strong>of</strong><strong>FGF</strong> generate PE formation (Yamanaka et al. 2010). At this early stage, <strong>FGF</strong>4 and <strong>FGF</strong> receptor 1(<strong>FGF</strong>R1) are expressed <strong>in</strong> <strong>the</strong> ICM and knockout mice <strong>of</strong> both genes die prior to or at gastrulation(Deng et al. 1994; Yamaguchi et al. 1994; Feldman et al. 1995). Fgf4 expression is activated by6
SOX2 and OCT4. Later, <strong>the</strong> PE and epiblast transiently express Fgf5 (Haub and Goldfarb 1991;Hebert et al. 1991).Gastrulation and germ-layer formationAt E5.5 <strong>the</strong> epiblast is formed as a cup-like structure surrounded by <strong>the</strong> visceral endoderm (VE)which patterns <strong>the</strong> epiblast and <strong>in</strong>itiates gastrulation (Figure 1-1A; (Rossant 2004)). It is at <strong>the</strong>posterior, proximal part <strong>of</strong> this cup that <strong>the</strong> primitive streak (PS) forms around E6.5 from where itstarts to migrate distally (Figure 1-1A). There is an anterior-posterior (A-P) pattern<strong>in</strong>g <strong>of</strong> <strong>the</strong>epiblast prior to gastrulation. Onset <strong>of</strong> PS formation is <strong>in</strong>itiated by a gradient <strong>of</strong> <strong>the</strong> transform<strong>in</strong>ggrowth factor β (TGFβ)-family member nodal and w<strong>in</strong>gless-type MMTV <strong>in</strong>tegration site 3(WNT3) <strong>signall<strong>in</strong>g</strong> from <strong>the</strong> posterior epiblast. Nodal generates a proximal-to-distal gradient andWNT3a forms a posterior-to-anterior gradient (Liu et al. 1999; Ben-Haim et al. 2006; Arnold andRobertson 2009). The nodal gradient moves distally, form<strong>in</strong>g <strong>the</strong> PS along <strong>the</strong> way and f<strong>in</strong>allyends at <strong>the</strong> distal-most part <strong>of</strong> <strong>the</strong> embryo, <strong>the</strong> node (Gadue et al. 2005). At <strong>the</strong> late streak stage,nodal expression is only found <strong>in</strong> <strong>the</strong> node where it forms a distal-to-proximal signal gradient. TheWNT3 expression pattern is restricted to <strong>the</strong> posterior epiblast dur<strong>in</strong>g PS-formation. At <strong>the</strong> sametime, <strong>the</strong> TGFβ family member bone morphogenetic prote<strong>in</strong> 4 (BMP4) from <strong>the</strong> extra-embryonicectoderm (ExE) signals to <strong>the</strong> adjacent epiblast. Thereby a proximal-to-distal signal gradientoppos<strong>in</strong>g that <strong>of</strong> nodal is formed (Lawson et al. 1999). The shape <strong>of</strong> <strong>the</strong>se morphogeneticgradients is modulated by <strong>the</strong> reciprocal expression <strong>of</strong> antagonists or <strong>in</strong>hibitors, <strong>the</strong>se be<strong>in</strong>g leftyand cerberus-like <strong>in</strong>hibit<strong>in</strong>g nodal-<strong>signall<strong>in</strong>g</strong>, dickkopf-related prote<strong>in</strong> 1 (DKK1) <strong>in</strong>hibit<strong>in</strong>gWNT3-<strong>signall<strong>in</strong>g</strong>, and chord<strong>in</strong> and nogg<strong>in</strong> <strong>in</strong>hibit<strong>in</strong>g BMP4-<strong>signall<strong>in</strong>g</strong> (Gadue et al. 2005).Thereby, <strong>the</strong> extension <strong>of</strong> <strong>the</strong> PS is restricted to <strong>the</strong> posterior side <strong>of</strong> <strong>the</strong> embryo.The primitive streak expresses <strong>the</strong> T-box transcription factor Brachyury (T) <strong>in</strong> migrat<strong>in</strong>g <strong>cells</strong> <strong>of</strong><strong>the</strong> PS and Mix1 homeobox-like (Mixl1), along with Even-skipped homeobox homolog 1 (Evx1)(Figure 1-1A; (Bastian and Gruss 1990; Dush and Mart<strong>in</strong> 1992; Kispert and Herrmann 1994; Nget al. 2005)). Goosecoid (Gsc) is expressed <strong>in</strong> <strong>the</strong> progress<strong>in</strong>g PS and localises to <strong>the</strong> anteriorstreak (Blum et al. 1992).7
- Page 1: PhD thesisCand.scient. Janny Marie
- Page 5: ResuméSukkersyge er en sygdom der
- Page 9: Table of contents1
- Page 12 and 13: ICMinner cell massIdInhibitor of di
- Page 16 and 17: Figure 1-1: Early embryo developmen
- Page 18 and 19: Figure 1-3: Regional expression of
- Page 20 and 21: The pluripotent stateThe pluripoten
- Page 25 and 26: There are four membrane-bound FGFRs
- Page 27: 2. AimsThe aim of this study was to
- Page 30 and 31: Developmental Biology 330 (2009) 28
- Page 32 and 33: 288 M. Hansson et al. / Development
- Page 34 and 35: 290 M. Hansson et al. / Development
- Page 36 and 37: 292 M. Hansson et al. / Development
- Page 38 and 39: 294 M. Hansson et al. / Development
- Page 40 and 41: 296 M. Hansson et al. / Development
- Page 42 and 43: 298 M. Hansson et al. / Development
- Page 44 and 45: 300 M. Hansson et al. / Development
- Page 46 and 47: 302 M. Hansson et al. / Development
- Page 48 and 49: 304 M. Hansson et al. / Development
- Page 50 and 51: Figure S2Figure S2: A subpopulation
- Page 52 and 53: Figure S4Figure S4: Expression of T
- Page 54 and 55: Figure S6Figure S6: qRT-PCR analyse
- Page 56 and 57: epithelium; Cdx2, expressed posteri
- Page 58 and 59: Figure 4-4: A high FGF4-concentrati
- Page 60 and 61: Figure 4-6: A 3-step protocol does
- Page 63 and 64: 5. Paper IIFGFR(IIIc)-activation in
- Page 65 and 66:
AbstractProgress in embryonic stem
- Page 67 and 68:
variants in their Ig-like domain II
- Page 69 and 70:
Cell count and proliferation assayC
- Page 71 and 72:
influence on the numbers of Sox17-G
- Page 73 and 74:
undifferentiated cells, we found th
- Page 75 and 76:
FGF4, 5, FGF8b and FGFR1, are expre
- Page 77 and 78:
with EdU-stain (blue sample); and w
- Page 79 and 80:
Olsen, S.K., J.Y. Li, C. Bromleigh,
- Page 81 and 82:
FiguresFigure 1: Screen for FGFR-is
- Page 83 and 84:
Figure 3: Activation of FGFRb or FG
- Page 87 and 88:
Opposite, Figure 6: In the absence
- Page 89 and 90:
6. General discussionEndoderm diffe
- Page 91 and 92:
Overall, the multitude of FGF-signa
- Page 93 and 94:
transplantation is the spread of an
- Page 96:
AcknowledgementsThe work presented
- Page 99 and 100:
Chambers, I., D. Colby, M. Robertso
- Page 101 and 102:
Hawkins, V.J. Wroblewski, D.S. Li,
- Page 103 and 104:
Nishikawa, S.I., S. Nishikawa, M. H
- Page 105 and 106:
Tanimizu, N., H. Saito, K. Mostov,